Notice: This company has been marked as potentially delisted and may not be actively trading. La Jolla Pharmaceutical (LJPC) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Innoviva Specialty Therapeutics to Present New Clinical Data From Its Development Pipeline and Broad Commercial Portfolio at IDWeek 2024October 15, 2024 | finance.yahoo.comLongboard Pharmaceuticals Shares Hit All-Time High on Takeover by LundbeckOctober 14, 2024 | marketwatch.comH. Lundbeck to Buy Longboard Pharmaceuticals for $2.6 Billion -- UpdateOctober 14, 2024 | marketwatch.comInnoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company ProgressMay 8, 2024 | finance.yahoo.comLa Jolla small business owners want lawful path to conduct business on the beachMarch 27, 2024 | msn.comScripps Green HospitalDecember 19, 2023 | health.usnews.comLa Jolla Pharmaceutical (NASDAQ: LJPC)September 25, 2023 | fool.comHepatorenal Syndrome Treatment Global Market Report 2023July 27, 2023 | finance.yahoo.comThalassemia Market Research | 2023-2030May 16, 2023 | marketwatch.comResults from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in The Lancet ...May 11, 2023 | businesswire.comKidney (Renal) Fibrosis Market Report | Research Across The World 2031May 10, 2023 | marketwatch.comKidney Fibrosis Treatment Market Dynamics and Drivers: 2023-2031May 8, 2023 | marketwatch.comBased on recent market research, the Kidney/Renal Fibrosis Treatment market is set to experience robust growth, with a CAGR of 7% from 2023 to 2030.May 5, 2023 | marketwatch.comFibrodysplasia Ossificans Progressiva Drug Market Historical Trends and Future Prospect till 2031May 4, 2023 | marketwatch.comLa Jolla High SchoolMay 3, 2023 | usnews.comCan The Proposed Antibiotic For Multidrug-Resistant Infections Fuel Innoviva's Revenue Growth?April 19, 2023 | markets.businessinsider.comThalassemia Market Complete Overview till 2030April 8, 2023 | marketwatch.comKidney Fibrosis Treatment Market-An Exclusive Study On Upcoming Trends And Growth Opportunities From 2023-2030April 7, 2023 | marketwatch.comKidney/Renal Fibrosis Treatment Market Size By 2031April 6, 2023 | marketwatch.comGlobal Thalassemia Market Size 2023 to 2026 Size and Share Survey ReportMarch 27, 2023 | marketwatch.comKidney Fibrosis Treatment Market Major Players, Anlysis and Forecast till 2031March 22, 2023 | marketwatch.comKidney/Renal Fibrosis Treatment Market Analysis 2023-2028, Newly Upgraded ReportMarch 20, 2023 | marketwatch.comScripps La Jolla HospitalsMarch 18, 2023 | health.usnews.comFibrodysplasia Ossificans Progressiva Drug Market Share, Segmentation and Forecast 2023-2028March 17, 2023 | marketwatch.comGlobal Fibrodysplasia Ossificans Progressiva Drug Market Size by Application (Hospital, Clinic, Research Center) Forecast from 2023 to 2028March 17, 2023 | marketwatch.comHeavy Metal Poisoning Drugs Market Size 2023 Research Report by Growth Rate Analysis and Forecast till 2027March 15, 2023 | marketwatch.comFibrodysplasia Ossificans Progressiva Drug Market Research Report 2023-2028 with Top Countries DataMarch 13, 2023 | marketwatch.comGlobal Thalassemia Market Growth Prospects, Geography, Drivers, and Restraints 2023 – 2030 By VMReportsMarch 12, 2023 | marketwatch.comKidney (Renal) Fibrosis Market Potential Analysis, by Trending Growth and CAGR 2023 to 2028March 10, 2023 | marketwatch.comUC San Diego Health-La Jolla and Hillcrest HospitalsFebruary 25, 2023 | health.usnews.comKidney Fibrosis Treatment Market Size 2023 : Emerging Technologies, Opportunity and Forecast to 2028February 18, 2023 | marketwatch.comFibrodysplasia Ossificans Progressiva Drug Market is Booming in Near Future 2023-2028February 16, 2023 | marketwatch.comKidney Fibrosis Treatment Market (New Report) to Witness A Pronounce Growth During 2023-2029February 15, 2023 | marketwatch.comJohnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&DFebruary 13, 2023 | benzinga.comThalassemia Market Growth and Status Explored in a New Research Report 2028February 9, 2023 | marketwatch.comLa Jolla, United States - Weather Forecasts | Maps | News - Yahoo WeatherFebruary 8, 2023 | yahoo.comKidney Fibrosis Treatment Market is booming in near Future 2023-2028January 20, 2023 | marketwatch.comKidney (Renal) Fibrosis Market 2023 : Detailed Analysis of Industry, Potential Growth, Attractive Valuation and Growth Forecast Up to 2028January 10, 2023 | marketwatch.comLa Jolla CoveDecember 31, 2022 | travel.usnews.comKidney (Renal) Fibrosis Market Size 2023 : Segment Overview, Company Profiles, Regional Analysis and Forecast 2028December 17, 2022 | marketwatch.comThis market report on Vasopressin for Vasoplegic Shock provides broad description of this industry.December 9, 2022 | marketwatch.comKidney (Renal) Fibrosis Market 2022 : Advance Technology, Latest Trend and Future Expansion by 2028 | 107 Pages ReportOctober 18, 2022 | marketwatch.comEverest Medicines Announces Approval of XERAVA® in Hong Kong for the Treatment of Complicated Intra-Abdominal InfectionsOctober 7, 2022 | markets.businessinsider.comLJPC Dec 2022 5.000 call(CONTRASeptember 2, 2022 | finance.yahoo.comTrading was temporarily halted for "LJPC" at 07:08 PM with a stated reason of "News pending."August 22, 2022 | marketbeat.comLa Jolla Pharmaceutical (NASDAQ:LJPC) Upgraded at StockNews.comStockNews.com raised shares of La Jolla Pharmaceutical from a "hold" rating to a "buy" rating in a research report on Wednesday.August 17, 2022 | marketbeat.comEverest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in TaiwanAugust 11, 2022 | markets.businessinsider.comLa Jolla Pharmaceutical (NASDAQ:LJPC) Upgraded to "C-" by TheStreetTheStreet raised shares of La Jolla Pharmaceutical from a "d+" rating to a "c-" rating in a report on Friday.August 2, 2022 | marketbeat.comLa Jolla Pharmaceutical Co Stock NewsJuly 28, 2022 | morningstar.comEquity Alert - The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. - LJPCJuly 16, 2022 | benzinga.com Get La Jolla Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for LJPC and its competitors with MarketBeat's FREE daily newsletter. Email Address I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. LJPC Media Mentions By Week LJPC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LJPC News Sentiment▼0.000.43▲Average Medical News Sentiment LJPC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LJPC Articles This Week▼00▲LJPC Articles Average Week Get La Jolla Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for LJPC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Exscientia News Allogene Therapeutics News Aligos Therapeutics News Aura Biosciences News Prime Medicine News Anavex Life Sciences News REGENXBIO News Alector News C4 Therapeutics News ProKidney News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LJPC) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding La Jolla Pharmaceutical Please log in to your account or sign up in order to add this asset to your watchlist. Share La Jolla Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
